###begin article-title 0
Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 285 303 285 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fibrinogen A (FGA)</italic>
###xml 305 324 305 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fibrinogen B (FGB) </italic>
###xml 328 347 328 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fibrinogen G (FGG) </italic>
Although plasma fibrinogen levels are related to cardiovascular risk, data regarding the role of fibrinogen genetic variation in myocardial infarction (MI) or coronary artery disease (CAD) etiology remain inconsistent. The purpose of the present study was to investigate the effect of fibrinogen A (FGA), fibrinogen B (FGB) and fibrinogen G (FGG) gene SNPs and haplotypes on susceptibility to CAD in a homogeneous Greek population.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
We genotyped for rs2070022, rs2070016, rs2070006 in FGA gene, the rs7673587, rs1800789, rs1800790, rs1800788, rs1800787, rs4681 and rs4220 in FGB gene and for the rs1118823, rs1800792 and rs2066865 SNPs in FGG gene applying an arrayed primer extension-based genotyping method (APEX-2) in a sample of CAD patients (n = 305) and controls (n = 305). Logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), before and after adjustment for potential confounders.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 33 47 33 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB, FGG </italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
None of the FGA and FGG SNPs and FGA, FGB, FGG and FGA-FGG haplotypes was associated with disease occurrence after adjustment. Nevertheless, rs1800787 and rs1800789 SNPs in FGB gene seem to decrease the risk of CAD, even after adjustment for potential confounders (OR = 0.42, 95%CI: 0.19-0.90, p = 0.026 and OR = 0.44, 95%CI:0.21-0.94, p = 0.039, respectively).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 28 42 28 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB, FGG </italic>
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
FGA and FGG SNPs as well as FGA, FGB, FGG and FGA-FGG haplotypes do not seem to be important contributors to CAD occurrence in our sample. On the contrary, FGB rs1800787 and rs1800789 SNPs seem to confer protection to disease onset lowering the risk by about 50% in homozygotes for the minor alleles.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Fibrinogen (Factor I) constitutes a water-soluble glycoprotein with a molecular weight of 340 kDa that is mainly synthesized in hepatocytes. It is a major factor of the coagulation system that participates in the process of hemostasis in two discrete pathways: Primarily, it is part of the final common pathway of the coagulation cascade. Secondarily, fibrinogen is bound to platelet GpIIb/IIIa membrane receptors and forms a web that provides stability to the newly-formed thrombus [1,2]. Apart from its role in coagulation reactions, fibrinogen participates in atherosclerosis development by promoting the adhesion of platelets and white blood cells to the endothelial surface [3-5] by promoting muscle cell proliferation and migration, as well as by modulating the binding of plasmin with its receptor [1]. Fibrinogen levels in plasma have been associated with coronary artery disease and myocardial infarction risk in prospective studies [6-9]. However, it is still unclear whether increased fibrinogen levels are causal to disease development or just a secondary phenomenon.
###end p 10
###begin p 11
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 355 357 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 392 403 380 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG-FGA-FGB</italic>
###xml 466 470 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 474 478 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 498 502 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
###xml 503 505 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Fibrinogen circulates in plasma as a dimer, composed of three pairs of polypeptide chains denoted Aa (alpha), Bb (beta) and gamma (gamma) encoded by fibrinogen alpha (FGA), beta (FGB) and gamma (FGG) genes respectively that are clustered on chromosome 4q31[10]. A variant of gamma chain, named gamma' is derived by alternate splicing of the primary mRNA [11]. The genes are arranged in order FGG-FGA-FGB, within a 50 kb region, with the transcriptional direction of FGG and FGA opposite to that of FGB [10].
###end p 11
###begin p 12
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
The study of SNPs and haplotypes of fibrinogen genes in relation to coronary artery disease (CAD) and myocardial infarction (MI) occurrence has yielded to date inconsistent results. Some investigators have reported associations between fibrinogen gene SNPs or haplotypes with MI or CAD occurrence [12-14], whereas other studies have not replicated these associations [15-18].
###end p 12
###begin p 13
###xml 369 378 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
Although numerous studies have been performed, scarce data concerning the role of fibrinogen gene SNPs or haplotypes in the Greek population are available. Therefore, we performed a retrospective case-control study involving 305 patients presenting with either CAD or acute coronary syndrome (ACS) and 305 healthy control subjects in order to investigate the impact of FGA, FGB and FGG gene SNPs and haplotypes on disease occurrence.
###end p 13
###begin title 14
Methods
###end title 14
###begin p 15
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
Study participants were recruited from 3 hospitals found in the area of Athens. Cases were subjects presenting with either ACS or stable CAD defined as >50% stenosis in at least one of the three main coronary vessels assessed by coronary angiography. ACS was defined as acute MI or unstable angina corresponding to class III of the Braunwald classification [19]. ACS patients have also undergone coronary angiography examination that verified the presence of significant stenosis.
###end p 15
###begin p 16
###xml 422 434 <span type="species:ncbi:9606">participants</span>
Controls were subjects with negative coronary angiography findings, or negative stress test, or subjects without symptoms of disease that were admitted at the same hospitals as cases and were free of any cardiovascular disease, cancer, or inflammatory diseases. Moreover, we excluded subjects with renal or hepatic disease from both study groups. The bioethics committee of Harokopio University approved the study and all participants gave their informed consent.
###end p 16
###begin p 17
Regarding the clinical characteristics of study subjects, hypercholesterolemia was defined as total cholesterol levels greater than 200 mg/dl or use of hypolipidemic medication, while hypertension was defined as blood pressure levels greater than 140/90 mm Hg or use of antihypertensive medication. We classified as diabetics subjects with blood glucose levels greater than 126 mg/dl or subjects that were under special diet or treatment. Finally, positive family history of myocardial infarction was defined as the presence of myocardial infarction in first degree male relatives at age < 55 years or in first degree female relatives at age <65 years.
###end p 17
###begin p 18
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 261 263 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 314 316 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 430 434 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
###xml 599 600 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Altogether 13 tag SNPs were genotyped for each individual in case-control samples. Carlson's algorithm was applied for SNP selection using Tagger implementation introduced in Haploview [20], where HapMap CEU was used as a reference population (with thresholds r2 >/= 0.8 and minor allele frequency (MAF) >/= 10%) [21]. SNPs were selected for each gene including 10 kb of both upstream and downstream sequences. A SNP rs1800787 in FGB gene was force-included to Tagger selection referring to the previously published data. Selected SNPs, as well as their location in the gene, are presented in Table 1.
###end p 18
###begin p 19
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
TagSNPs for the FGA, FGB and FGG genes.
###end p 19
###begin p 20
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aAlleles are depicted from the coding strand for all SNPs except of rs2070022, rs2070016, rs2070006, rs2066865 and rs1800792 that are depicted from the non-coding one.
###end p 20
###begin p 21
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Genomic DNA was extracted from whole blood using the salting-out method [22]. Genotyping was performed using an arrayed primer extension-based genotyping method (APEX-2). This method allows multiplex DNA amplification and detection of SNPs on microarrays via four-color single-base primer extension [23].
###end p 21
###begin p 22
The standard chi-square test was used to test for deviations from Hardy-Weinberg equilibrium and to evaluate the differences in genotype distributions between cases and controls.
###end p 22
###begin p 23
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
The odds ratios (ORs) were calculated using logistic regression under the assumption of the additive, dominant and recessive models. Logistic regression including age, sex, and the presence of diabetes, hypertension, hypercholesterolemia and smoking as covariates was used to calculate adjusted ORs. Analysis of single SNPs effects was performed using PLINK 1.05 [24].
###end p 23
###begin p 24
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG-FGA </italic>
###xml 96 108 96 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG-FGB </italic>
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 476 478 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
Haplotypes were constructed for each gene separately and for FGG-FGA genes. We did not consider FGA-FGG-FGB haplotypes in the analysis due to weak LD (Linkage Disequilibrium) between FGA-FGG and FGB variants. THESIAS software [25] was used to calculate haplotype frequencies in cases and controls as well as ORs and respective 95% confidence intervals before and after adjustment for the aforementioned covariates using the most common haplotype as a reference. LD measures (r2 and D') between SNPs were calculated using Haploview [20]. D' values are given in Figure 1. All p-values are based on two-sided tests and compared to a significance level of 5%.
###end p 24
###begin p 25
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Linkage disequilibrium structure</bold>
Linkage disequilibrium structure. D' values between SNPs in FGA, FGB and FGG genes.
###end p 25
###begin p 26
Power analysis was performed using Quanto 1.2 software.
###end p 26
###begin title 27
Results
###end title 27
###begin p 28
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 268 276 <span type="species:ncbi:9606">Patients</span>
Table 2 summarises the characteristics of 305 CAD and ACS cases and 305 control subjects. The two study groups differed in a predictable manner, i.e. cases exhibited a higher prevalence of risk factors such as hypercholesterolemia, hypertension, diabetes and smoking. Patients presenting ACS represented 62.6% of all cases. Mean age, as well as the percentage of male subjects was lower among controls than in cases. BMI did not present statistically significant differences between the two study groups. Although hypercholesterolemia was most common among cases, total cholesterol and LDL levels are higher in the control group, due to the less frequent use of hypolipidemic medication.
###end p 28
###begin p 29
###xml 27 35 <span type="species:ncbi:9606">patients</span>
General characteristics of patients and controls included in our study.
###end p 29
###begin p 30
All SNPs were in Hardy-Weinberg equilibrium except for FGB rs7673587 and rs1800788 SNPs (p < 0.05) that were excluded from subsequent analysis.
###end p 30
###begin p 31
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
Logistic regression analysis was performed for FGA, FGB and FGG gene SNPs separately, under the assumption of the additive, dominant and recessive models. ORs and 95% CIs were calculated before and after adjustment for age, sex and the presence of hypercholesterolemia, hypertension, diabetes and smoking. Four SNPs were nominally associated with disease in at least one model of inheritance (Table 3).
###end p 31
###begin p 32
Results from logistic regression analysis for SNPs with significant associations before adjustment.
###end p 32
###begin p 33
###xml 46 55 46 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
Results from logistic regression analysis for FGA, FGB and FGG gene SNPs that were significantly associated with disease, before adjustment for confounding variables.
###end p 33
###begin p 34
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a adjustment for age, sex and the presence of hypercholesterolemia, hypertension, diabetes and smoking
###end p 34
###begin p 35
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
Thus, carriers of one minor allele of rs2070006 in FGA gene exhibited an OR of 1.26 (95% CI:0.99-1.59, p = 0.055), that after adjustment was 1.26 (95% CI:0.98-1.63, p = 0.081). When carriers of the minor allele were grouped together, i.e. when modeled dominantly, the unadjusted OR was 1.51 (95% CI: 1.09-2.09, p = 0.013), while after adjustment OR was 1.39 (95% CI:0.97-1.99, p = 0.077).
###end p 35
###begin p 36
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
In the case of FGB gene two SNPs, rs1800787 and rs1800789, were associated with disease occurrence in the recessive model, and the association remained significant after adjustment for the confounding variables (OR = 0.47, 95% CI:0.24-0.92, p = 0.026 and OR = 0.50, 95% CI:0.27-0.96, p = 0.039, respectively). The association of those SNPs with disease was significant even after further adjustment for obesity (BMI > 27) (OR = 0.40, 95% CI:0.18-0.18, p = 0.023 and OR = 0.38, 95% CI:0.17-0.85, p = 0.019, respectively).
###end p 36
###begin p 37
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
Rs2066865 in FGG gene showed borderline association with CAD. For carriers of one minor allele, the unadjusted OR was 1.31 (95% CI:0.99-1.75, p = 0.062), while after adjustment it was 1.32 (95% CI:0.97-1.80, p = 0.077). Results did not differ much when the dominant model was considered. No other SNP in FGA, FGB and FGG genes was associated with disease occurrence.
###end p 37
###begin p 38
###xml 9 10 9 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 39 53 39 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB, FGG </italic>
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 321 329 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
In Table 4 the inferred haplotypes for FGA, FGB, FGG and FGA-FGG SNPs with frequency >5% are presented. In Table 5 the ORs and 95% CIs are presented for each haplotype before and after adjustment for the same confounding variables as in the case of single SNPs. We used the most common haplotype as a reference category. FGA-FGG H3 haplotype TGATTA bearing the 2 minor alleles of rs2070006 and rs2066865 was associated with CAD in the unadjusted analysis (OR = 1.42, 95% CI:1.02-1.98, p = 0.040), but after adjustment for confounding factors the statistical significance was lost (OR = 1.38, 95% CI: 0.94-2.02, p = 0.098).
###end p 38
###begin p 39
###xml 15 29 15 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB, FGG </italic>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
Haplotypes for FGA, FGB, FGG and FGA-FGG gene SNPs with frequencies >5%.
###end p 39
###begin p 40
Bold and underlined letters indicate SNP minor alleles.
###end p 40
###begin p 41
Frequencies, ORs and 95% CIs for CAD in relation to the most frequent haplotypes.
###end p 41
###begin p 42
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a adjustment for age, sex and the presence of hypercholesterolemia, hypertension, diabetes and smoking
###end p 42
###begin p 43
Further adjustment for lipid levels, i.e. total cholesterol, LDL cholesterol and HDL cholesterol, did not significantly affect our results concerning both single SNP and haplotype effects.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Evidence from epidemiologic studies and meta-analyses suggests that increased plasma fibrinogen levels are related to increased coronary artery disease risk [6]. Despite the existence of numerous studies that support an association between plasma fibrinogen levels and certain SNPs or haplotypes [13,15,26-28], data linking the latter with CAD occurrence still remain controversial.
###end p 45
###begin p 46
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
In the present study we used a tagSNP approach to evaluate the role of genetic variation across FGA, FGB and FGG genes in the occurrence of coronary artery disease in a homogeneous Greek population sample of 305 patients and 305 controls. CAD was defined as either presence of angiographically proven significant stenosis in coronary vessels or ACS.
###end p 46
###begin p 47
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
The allele frequencies in controls, observed in our study, were similar to the ones reported for HapMap CEU reference population. Rs2070006 and rs2066865 SNPs in FGA and FGG genes respectively were nominally associated with increased risk of CAD both in the additive and dominant models of inheritance, but statistical significance was lost after adjustment. On the other hand, homozygotes for the minor alleles of rs1800787 and rs1800789 SNPs in FGB gene exhibited a decreased risk of CAD remaining statistically significant after adjustment for confounding factors.
###end p 47
###begin p 48
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG</italic>
Haplotype analysis showed that when FGA and FGG gene SNPs were considered together, FGA-FGG-H3 haplotype TGATTA bearing the minor alleles of both rs2070006 and rs2066865 SNPs was associated with an increase in disease risk in the unadjusted analysis, but after adjustment this association disappeared.
###end p 48
###begin p 49
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 84 98 84 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB, FGG </italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG-FGA </italic>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG-FGB </italic>
###xml 427 436 427 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA, FGB </italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
Therefore, our results do not reveal an important role of FGA and FGG gene SNPs and FGA, FGB, FGG and FGA-FGG haplotypes in CAD occurrence and are in accordance with previously published data. The initial associations published by Mannila et al. [12-14] supporting a role of FGG-FGA and FGG-FGB haplotypes in myocardial infarction risk have not been replicated by other investigators that studied single SNPs and haplotypes in FGA, FGB and FGG genes in MI or CAD phenotypes [15-18].
###end p 49
###begin p 50
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 412 414 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 427 429 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Rs1800790 SNP in FGB gene was shown to be associated with decreased MI risk applying the recessive model in a meta-analysis [29]. Recently, the same SNP was found to exert protective effect against premature myocardial infarction in a Greek population [30]. In our study we could not replicate these findings. Interestingly, we found rs1800787 and rs1800789 variants, that are highly correlated with rs1800790 (r2 = 0.943 and r2 = 0.928, respectively), to decrease disease risk by about 50%, when modeled recessively. One could hypothesize that the effect of rs1800790, found in the previous studies, is attributed to the strong LD with SNPs rs1800787 and/or rs1800789 - these two tightly linked SNPs most likely are representing the same signal of association with the disease and either of these SNPs might be the functional one. Previous studies that included these SNPs, or others that are in strong LD with them, resulted in negative findings, but in those studies the effect of the SNPs in the recessive model was not considered [15,16].
###end p 50
###begin p 51
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
Our study is limited by the small sample size. A posterior analysis revealed that the power of our sample to detect an odds ratio from 0.4-0.5 was 0.5-0.8, depending on minor allele frequency, with significance level alpha 0.05. We cannot exclude the possibility of a modest effect of SNPs or haplotypes in disease predisposition that would possibly be apparent in a larger sample. Nevertheless, our sample size is similar to that of Mannila et al. that studied eight fibrinogen SNPs in 377 post-infarction patients and 387 healthy individuals and found that fibrinogen haplotypes, and not SNPs, were associated with the risk of MI [14].
###end p 51
###begin p 52
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
Another important limitation of our study is the lack of information concerning the effect of SNPs or haplotypes on fibrinogen levels. Moreover, we have not taken into account the effect of proinflammatory markers, such as IL-6, that have been shown to modify the effect of SNPs on fibrinogen levels [26], and possibly the effect of SNPs in disease risk. Nevertheless, in the multivariate analysis we have adjusted our models for the presence of obesity, hypertension, hypercholesterolemia and diabetes that represent in a way the proinflammatory status and may partially compensate for the lack of information for the levels of specific inflammatory markers.
###end p 52
###begin p 53
The results of our study should be interpreted with caution, taking into account the multiple tests performed. If we applied the conservative Bonferroni's correction then the level of statistical significance should be 0.001 and none of our associations would remain significant. Nevertheless, the fact that rs1800787 and rs1800789 are highly correlated with rs1800790 that has been previously associated with disease increases our confidence for our results.
###end p 53
###begin p 54
Futhermore, we cannot exclude the possibility of misclassification of subjects with silent CAD in the control group among subjects that were not subjected to coronary angiography or stress test and who reported absence of symptoms of disease. Finally, cases with fatal MI were not included. Thus, we cannot rule out the possibility that this polymorphism may predispose for more severe disease phenotypes.
###end p 54
###begin title 55
Conclusions
###end title 55
###begin p 56
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA </italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGG </italic>
###xml 78 81 78 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA</italic>
###xml 83 92 83 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB, FGG </italic>
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGA-FGG </italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGB </italic>
The results of the present study suggest that FGA and FGG variants as well as FGA, FGB, FGG and FGA-FGG haplotypes do not seem to be important contributors to CAD occurence in our Greek population. Nevertheless, FGB rs1800787 and rs1800789 variants, in the recessive model, seem to confer protection to disease onset lowering the risk by about 50%.
###end p 56
###begin title 57
Competing interests
###end title 57
###begin p 58
The authors declare that they have no competing interests.
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
EVT participated in study design, sample recruitment, DNA isolation, statistical analysis, interpretation of data and drafted the manuscript. TN participated in SNP selection, genotyping and manuscript revision. JS participated in genotyping. VP participated in sample recruitment and helped to draft the manuscript. PF participated in sample recruitment and DNA isolation. GK participated in sample recruitment and manuscript revision. VP participated in sample recruitment and DNA isolation. DR and NZ participated in sample recruitment. AM coordinated SNP selection and genotyping. GVD was the general coordinator of the study.
###end p 60
###begin p 61
All authors read and approved the final manuscript.
###end p 61
###begin title 62
Pre-publication history
###end title 62
###begin p 63
The pre-publication history for this paper can be accessed here:
###end p 63
###begin p 64

###end p 64
###begin title 65
Acknowledgements
###end title 65
###begin p 66
The project was financially supported by the General Secretary of Research and Technology (PENED 03EDelta474) (EVT and GVD), by the Targeted Financing from the Estonian Ministry of Education and Research (SF0180142s08), EU FP7 grant ECOGENE (#205419, EBC) and by EU via the European Regional Development Fund grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu (TN, JS and AM).
###end p 66
###begin article-title 67
Fibrin(ogen) in cardiovascular disease: an update
###end article-title 67
###begin article-title 68
Fibrinogen--marker or mediator of vascular disease?
###end article-title 68
###begin article-title 69
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging
###end article-title 69
###begin article-title 70
###xml 93 98 <span type="species:ncbi:9606">human</span>
Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells
###end article-title 70
###begin article-title 71
Fibrinogen binding to ICAM-1 on EA.hy 926 endothelial cells is dependent on an intact cytoskeleton
###end article-title 71
###begin article-title 72
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies
###end article-title 72
###begin article-title 73
###xml 111 122 <span type="species:ncbi:9606">participant</span>
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis
###end article-title 73
###begin article-title 74
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature
###end article-title 74
###begin article-title 75
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update
###end article-title 75
###begin article-title 76
Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion
###end article-title 76
###begin article-title 77
###xml 27 32 <span type="species:ncbi:9606">human</span>
gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing
###end article-title 77
###begin article-title 78
Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction
###end article-title 78
###begin article-title 79
###xml 75 78 <span type="species:ncbi:9606">men</span>
The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration
###end article-title 79
###begin article-title 80
Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction
###end article-title 80
###begin article-title 81
Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study
###end article-title 81
###begin article-title 82
Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study
###end article-title 82
###begin article-title 83
Fibrinogen genes and myocardial infarction: a haplotype analysis
###end article-title 83
###begin article-title 84
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels
###end article-title 84
###begin article-title 85
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities
###end article-title 85
###begin article-title 86
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 86
###begin article-title 87
Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium
###end article-title 87
###begin article-title 88
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 88
###begin article-title 89
Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays
###end article-title 89
###begin article-title 90
PLINK: a tool set for whole-genome association and population-based linkage analyses
###end article-title 90
###begin article-title 91
Specific haplotypes of the P-selectin gene are associated with myocardial infarction
###end article-title 91
###begin article-title 92
Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study
###end article-title 92
###begin article-title 93
A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study
###end article-title 93
###begin article-title 94
Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration
###end article-title 94
###begin article-title 95
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review
###end article-title 95
###begin article-title 96
G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece
###end article-title 96

